MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit From Adjuvant Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA09.03 Multiple Pathological Variables Predict Efficacy of Adjuvant Chemotherapy in Primary Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated With Survival in Elderly Patients With Lung Adenocarcinoma

Cancers
Cancer ResearchOncology
2018English

TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2020English

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

Comprehensive Analysis of Prognostic Immune‐related Genes in the Tumor Microenvironment of Lung Adenocarcinoma

2020English

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical Cancer Research
Cancer ResearchOncology
2007English

P1.16-63 the Value of Adjuvant Chemotherapy in Patients With Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-114 the Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients With Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy